646 related articles for article (PubMed ID: 25915904)
21. Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry.
Cools F; Wollaert B; Vervoort G; Verstraete S; Voet J; Hermans K; Heyse A; De Wolf A; Hollanders G; Boussy T; Anné W; Vercammen J; Faes D; Beutels M; Mairesse G; Purnode P; Blankoff I; Vandergoten P; Capiau L; Allu J; Bassand JP; Kayani G;
Acta Cardiol; 2019 Aug; 74(4):309-318. PubMed ID: 30369290
[No Abstract] [Full Text] [Related]
22. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
[TBL] [Abstract][Full Text] [Related]
23. Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey.
Lane DA; Dagres N; Dan GA; García Seara J; Iliodromitis K; Lenarczyk R; Lip GYH; Mansourati J; Marín F; Scherr D; Potpara TS
Europace; 2019 Jul; 21(7):1116-1125. PubMed ID: 30874724
[TBL] [Abstract][Full Text] [Related]
24. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF).
Kirchhof P; Ammentorp B; Darius H; De Caterina R; Le Heuzey JY; Schilling RJ; Schmitt J; Zamorano JL
Europace; 2014 Jan; 16(1):6-14. PubMed ID: 24084680
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry.
Steg PG; Greenlaw N; Tendera M; Tardif JC; Ferrari R; Al-Zaibag M; Dorian P; Hu D; Shalnova S; Sokn FJ; Ford I; Fox KM;
JAMA Intern Med; 2014 Oct; 174(10):1651-9. PubMed ID: 25110899
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological therapy following acute coronary syndromes in patients with atrial fibrillation: how do we balance ischaemic risk with bleeding risk?
Fake AL; Harding SA; Matsis PP; Larsen PD
N Z Med J; 2016 May; 129(1435):39-49. PubMed ID: 27355167
[TBL] [Abstract][Full Text] [Related]
27. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
[TBL] [Abstract][Full Text] [Related]
28. Management of outpatients in France with stable coronary artery disease. Findings from the prospeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) registry.
Danchin N; Ferrieres J; Guenoun M; Cattan S; Rushton-Smith SK; Greenlaw N; Ferrari R; Steg PG;
Arch Cardiovasc Dis; 2014; 107(8-9):452-61. PubMed ID: 25128934
[TBL] [Abstract][Full Text] [Related]
29. Relationship of Provider and Practice Volume to Performance Measure Adherence for Coronary Artery Disease, Heart Failure, and Atrial Fibrillation: Results From the National Cardiovascular Data Registry.
Fleming LM; Jones P; Chan PS; Andrei AC; Maddox TM; Farmer SA
Circ Cardiovasc Qual Outcomes; 2016 Jan; 9(1):48-54. PubMed ID: 26646817
[TBL] [Abstract][Full Text] [Related]
30. Stroke prevention in atrial fibrillation and 'real world' adherence to guidelines in the Balkan Region: The BALKAN-AF Survey.
Potpara TS; Dan GA; Trendafilova E; Goda A; Kusljugic Z; Manola S; Music L; Musetescu R; Badila E; Mitic G; Paparisto V; Dimitrova ES; Polovina MM; Petranov SL; Djergo H; Loncar D; Bijedic A; Brusich S; Lip GY;
Sci Rep; 2016 Feb; 6():20432. PubMed ID: 26869284
[TBL] [Abstract][Full Text] [Related]
31. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
32. Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Goto K; Nakai K; Shizuta S; Morimoto T; Shiomi H; Natsuaki M; Yahata M; Ota C; Ono K; Makiyama T; Nakagawa Y; Furukawa Y; Kadota K; Takatsu Y; Tamura T; Takizawa A; Inada T; Doi O; Nohara R; Matsuda M; Takeda T; Kato M; Shirotani M; Eizawa H; Ishii K; Lee JD; Takahashi M; Horie M; Takahashi M; Miki S; Aoyama T; Suwa S; Hamasaki S; Ogawa H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
Am J Cardiol; 2014 Jul; 114(1):70-8. PubMed ID: 24925801
[TBL] [Abstract][Full Text] [Related]
33. Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry.
Gullón A; Suárez C; Díez-Manglano J; Formiga F; Cepeda JM; Pose A; Camafort M; Castiella J; Rovira E; Mostaza JM;
Med Clin (Barc); 2017 Mar; 148(5):204-210. PubMed ID: 27993408
[TBL] [Abstract][Full Text] [Related]
34. Coronary artery disease in outpatients with nonvalvular atrial fibrillation: results from the multicenter RAMSES study.
Dogan V; Başaran Ö; Beton O; Tekinalp M; Bolat I; Kalaycioğlu E; Aykan AÇ; Taşar O; Şafak Ö; Kalçik M; Yaman M; Kirma C; Biteker M
Coron Artery Dis; 2016 Sep; 27(6):497-503. PubMed ID: 27182772
[TBL] [Abstract][Full Text] [Related]
35. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
[No Abstract] [Full Text] [Related]
36. Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation.
Fox KAA; Velentgas P; Camm AJ; Bassand JP; Fitzmaurice DA; Gersh BJ; Goldhaber SZ; Goto S; Haas S; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Dabrowski E; Luo K; Gibbs L; Kakkar AK;
JAMA Netw Open; 2020 Feb; 3(2):e200107. PubMed ID: 32101311
[TBL] [Abstract][Full Text] [Related]
37. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries.
Patti G; Pecen L; Lucerna M; Huber K; Rohla M; Renda G; Siller-Matula J; Schnabel RB; Cemin R; Kirchhof P; De Caterina R
Int J Cardiol; 2018 Nov; 270():160-166. PubMed ID: 30220376
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.
Corbalan R; Bassand JP; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK;
JAMA Cardiol; 2019 Jun; 4(6):526-548. PubMed ID: 31066873
[TBL] [Abstract][Full Text] [Related]
40. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
Stenestrand U; Lindbäck J; Wallentin L;
Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]